The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dooms, H.
Right arrow Articles by Grooten, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dooms, H.
Right arrow Articles by Grooten, J.
The Journal of Immunology, 1998, 161: 2141-2150.
Copyright © 1998 by The American Association of Immunologists

Quiescence-Inducing and Antiapoptotic Activities of IL-15 Enhance Secondary CD4+ T Cell Responsiveness to Antigen1

Hans Dooms, Marjory Desmedt, Sabine Vancaeneghem, Pieter Rottiers, Vera Goossens, Walter Fiers and Johan Grooten2

Department of Molecular Biology, Molecular Immunology Unit, Flanders Interuniversity Institute for Biotechnology and University of Ghent, Ghent, Belgium

IL-15 shows functional redundancy with IL-2 due to its usage of the ß and {gamma}c subunit of the IL-2R. Yet, the requirement of IL-15 for an IL-15R{alpha} chain for high affinity interaction and the separate cellular sources of IL-2 and IL-15 suggest divergent activities for both cytokines. We compared the growth-inducing and proapoptotic or antiapoptotic activities of IL-15 and IL-2 on mature CD4+ T lymphocytes in the presence or absence of TCR occupancy. We found that the nature of IL-15 activity was critically dependent on the activation status of the T cells. In the absence of TCR triggering, IL-15 did not exert the growth factor activity of IL-2, but induced a quiescent phenotype, characterized by maintenance of the cells in the G0/G1 phase of the cell cycle and down-regulation of CD25, CD71, and CD95 expression. In the presence of appropriate TCR engagement, the IL-15-induced quiescent T cells were resistant against TCR-induced cell death and proliferated strongly. IL-2-treated cells, on the contrary, were sensitized to cell death, resulting in a negative feedback on cellular expansion and weak proliferative responsiveness. Consecutive action of IL-15 during the distinct phases of an in vitro immune response markedly increased the cell output of a second antigenic stimulation, as compared with IL-2. These results imply that during immune reactivity in vivo, IL-15 may take over from the transiently available IL-2 the role of survival factor but not of growth factor, hence promoting the long term maintenance of resting, Ag-experienced CD4+ T cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Ruckert, K. Brandt, A. Braun, H.-G. Hoymann, U. Herz, V. Budagian, H. Durkop, H. Renz, and S. Bulfone-Paus
Blocking IL-15 Prevents the Induction of Allergen-Specific T Cells and Allergic Inflammation In Vivo
J. Immunol., May 1, 2005; 174(9): 5507 - 5515.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-M. Lee, C.-Y. Chung, W.-W. Chiang, Y.-H. Liou, C.-F. Chen, and N.-S. Liao
IL-15R{alpha} Is a Negative Regulator of TCR-Activated Proliferation in CD4+ T Cells
J. Immunol., September 1, 2004; 173(5): 3155 - 3164.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Dooms, E. Kahn, B. Knoechel, and A. K. Abbas
IL-2 Induces a Competitive Survival Advantage in T Lymphocytes
J. Immunol., May 15, 2004; 172(10): 5973 - 5979.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. J. P. M. Koenen, E. Fasse, and I. Joosten
IL-15 and Cognate Antigen Successfully Expand De Novo-Induced Human Antigen-Specific Regulatory CD4+ T Cells That Require Antigen-Specific Activation for Suppression
J. Immunol., December 15, 2003; 171(12): 6431 - 6441.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Dubois, W. Shou, L. S. Haneline, S. Fleischer, T. A. Waldmann, and J. R. Muller
Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T cells
PNAS, November 25, 2003; 100(24): 14169 - 14174.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Berard, K. Brandt, S. B. Paus, and D. F. Tough
IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells
J. Immunol., May 15, 2003; 170(10): 5018 - 5026.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Bulanova, V. Budagian, Z. Orinska, H. Krause, R. Paus, and S. Bulfone-Paus
Mast Cells Express Novel Functional IL-15 Receptor {alpha} Isoforms
J. Immunol., May 15, 2003; 170(10): 5045 - 5055.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. P. Rubinstein, A. N. Kadima, M. L. Salem, C. L. Nguyen, W. E. Gillanders, and D. J. Cole
Systemic Administration of IL-15 Augments the Antigen-Specific Primary CD8+ T Cell Response Following Vaccination with Peptide-Pulsed Dendritic Cells
J. Immunol., November 1, 2002; 169(9): 4928 - 4935.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. I. Kingsley, M. Karim, A. R. Bushell, and K. J. Wood
CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses
J. Immunol., February 1, 2002; 168(3): 1080 - 1086.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T.-S. Wu, J.-M. Lee, Y.-G. Lai, J.-C. Hsu, C.-Y. Tsai, Y.-H. Lee, and N.-S. Liao
Reduced Expression of Bcl-2 in CD8+ T Cells Deficient in the IL-15 Receptor {alpha}-Chain
J. Immunol., January 15, 2002; 168(2): 705 - 712.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Bulanova, V. Budagian, T. Pohl, H. Krause, H. Durkop, R. Paus, and S. Bulfone-Paus
The IL-15R{alpha} Chain Signals Through Association with Syk in Human B Cells
J. Immunol., December 1, 2001; 167(11): 6292 - 6302.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Paiardini, D. Galati, B. Cervasi, G. Cannavo, L. Galluzzi, M. Montroni, D. Guetard, M. Magnani, G. Piedimonte, and G. Silvestri
Exogenous Interleukin-2 Administration Corrects the Cell Cycle Perturbation of Lymphocytes from Human Immunodeficiency Virus-Infected Individuals
J. Virol., November 15, 2001; 75(22): 10843 - 10855.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Dooms, T. Van Belle, M. Desmedt, P. Rottiers, and J. Grooten
Interleukin-15 redirects the outcome of a tolerizing T-cell stimulus from apoptosis to anergy
Blood, August 1, 2000; 96(3): 1006 - 1012.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Yamada, T. Nakamura, G. Matsuzaki, Y. Iwamoto, and K. Nomoto
TCR-Independent Activation of Extrathymically Developed, Self Antigen-Specific T Cells by IL-2/IL-15
J. Immunol., February 15, 2000; 164(4): 1746 - 1752.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Hayashida, Y. Shimaoka, T. Ochi, and P. E Lipsky
Rheumatoid Arthritis Synovial Stromal Cells Inhibit Apoptosis and Up-Regulate Bcl-xL Expression by B Cells in a CD49/CD29-CD106-Dependent Mechanism
J. Immunol., January 15, 2000; 164(2): 1110 - 1116.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-G. Lai, V. Gelfanov, V. Gelfanova, L. Kulik, C.-L. Chu, S.-W. Jeng, and N.-S. Liao
IL-15 Promotes Survival But Not Effector Function Differentiation of CD8+ TCR{alpha}{beta}+ Intestinal Intraepithelial Lymphocytes
J. Immunol., December 1, 1999; 163(11): 5843 - 5850.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Azimi, M. Nagai, S. Jacobson, and T. A. Waldmann
IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients
PNAS, December 4, 2001; 98(25): 14559 - 14564.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.